HealthTech

PharmEasy’s Uneasy State

Published

on

[ad_1]

Here’s a curious thought for you this Sunday: Whenever a startup acquires a legacy firm or a bigger player, it has usually not worked out.

Take the billion-dollar deal between BYJU’S and coaching giant Aakash, which has more or less failed in light of the troubles for BYJU’s. Or ride-hailing startup Ola, which splurged nearly $200 Mn to acquire FoodPanda and enter food delivery, before realising it was not just about acquiring a company. 

There are exceptions of course, but more of than not, it has not turned out to be a good…

[ad_2]

Source link

Exit mobile version